In the last trading session, 0.2 million shares of the Omega Therapeutics Inc (NASDAQ:OMGA) were traded, and its beta was 1.71. Most recently the company’s share price was $0.55, and it changed around -$0.02 or -3.04% from the last close, which brings the market valuation of the company to $30.40M. OMGA currently trades at a discount to its 52-week high of $4.46, offering almost -710.91% off that amount. The share price’s 52-week low was $0.52, which indicates that the current value has risen by an impressive 5.45% since then. We note from Omega Therapeutics Inc’s average daily trading volume that its 10-day average is 0.37 million shares, with the 3-month average coming to 343.34K.
Omega Therapeutics Inc stock received a consensus recommendation rating of Buy, based on a mean score of 2.00. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 1 recommended OMGA as a Hold, whereas 4 deemed it a Buy, and 0 rated it as Underweight.
Omega Therapeutics Inc (NASDAQ:OMGA) trade information
Instantly OMGA has showed a red trend with a performance of -3.04% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 0.8000 on recent trading dayincreased the stock’s daily price by 31.25%. The company’s shares are currently down -26.37% year-to-date, but still down -22.24% over the last five days. On the other hand, Omega Therapeutics Inc (NASDAQ:OMGA) is -35.87% down in the 30-day period. We can see from the shorts that 6.36 million shares have been sold at a short interest cover period of 16.34 day(s).
The consensus price target as assigned by Wall Street analysts is $9, which translates to bulls needing to increase their stock price by 93.89% from its current value. Analyst projections state that OMGA is forecast to be at a low of $7 and a high of $11.
Omega Therapeutics Inc (OMGA) estimates and forecasts
Omega Therapeutics Inc share prices are performing particularly well compared to other companies within the same industry. As is evident from the statistics, the company’s shares have fallen -70.16 percent over the past six months and at a 33.89% annual growth rate that is well above the industry average of 16.50%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -48.08%.
OMGA Dividends
Omega Therapeutics Inc’s next quarterly earnings report is expected to be released in February.
Omega Therapeutics Inc (NASDAQ:OMGA)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 1.62% of Omega Therapeutics Inc shares, and 90.43% of them are in the hands of institutional investors. The stock currently has a share float of 91.92%. Omega Therapeutics Inc stock is held by 70.0 institutions, with FLAGSHIP PIONEERING INC. being the largest institutional investor. By 2024-06-30, it held 52.9924% of the shares, which is about 29.23 million shares worth $60.5 million.
FMR LLC, with 11.3181% or 6.24 million shares worth $12.92 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
